EpiPen Maker Offers Discount After Outrage


Following extremely critical news coverage and condemnation from politicians including Hillary Clinton, pharmaceutical maker Mylan has agreed to offer a discount to the patient cost of the EpiPen, the emergency epinephrine shot that stops anaphylaxis. The cost of the severe-allergy treatment had increased by more than 400 percent in the past 10 years.

Mylan said today that it would provide a savings card that covers $300 of the EpiPen 2-Pak, which would reduce the out-of-pocket cost for the drug by 50 percent. Sen. Amy Klobuchar (D-MN) had asked this week that the Senate Judiciary Committee investigate the price hike. Klobuchar, whose daughter relies on the drug, called the price spike “unjustified.” Read more at REUTERS.



  1. There are only two solutions to this problem:

    1) Have the government regulate the price of drugs.
    2) Have the government allow competition.

    (2) would require the end of patents and would therefore mean the end of the development of new drugs and devices. So we need to do (1) which is what almost all other countries do.

    • I do not think there is any patent on epinephrine, nor that it is particularly expensive. I imagine the customer pays for a very efficient, quick and error-proof injection device, which is designed to be used by the very person in anaphylactic shock, or by any squeamish and terrified layperson at the scene.

      Lots of EpiPens expire without being used. Perhaps the government and Mylan could negotiate a program which replaces EpiPens close to expiration date at a discounted price. We all benefit from lots of emergency epinephrine dispensers being out there, because everybody can have an anaphylactic shock, even people with no history of allergy.